Niloofar Farsiu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Niloofar Farsiu has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
- Mohsen Nakhaie
Research Center of Tropical and Infectious Diseases Kerman University of Medical Sciences Kerman Iran
8 shared publications Javad Charostad
Department of Microbiology, Faculty of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
4 shared publicationsAmirhossein Shahpar
Gastroenterology and Hepatology Research Center Institute of Basic and Clinical Physiology Sciences Kerman University of Medical Sciences Kerman Iran
3 shared publicationsMohammad Pardeshenas
Department of Microbiology, School of Medicine, Kerman University of Medical Sciences, Kerman, Iran
3 shared publicationsNazanin Zeinali Nezhad
Physiology Research Center Kerman University of Medical Sciences Kerman Iran
3 shared publicationsDavood Bashash
Department of Hematology and Blood Banking, School of Allied Medical Sciences Shahid Beheshti University of Medical Sciences Tehran Iran
2 shared publications
Latest Publications
- Open Access
- 16 April 2026
- Published by Elsevier in Virus Research
- Vol. 368, 199730
From legacy to innovation: A comprehensive review of vaccine platforms against viral infections
- 16 April 2026
- Published by Elsevier in Virus Research
- Vol. 368, 199730
Open AccessFrom legacy to innovation: A comprehensive review of vaccine platforms against viral infections
- Open Access
- 17 March 2026
- Published by Wiley in Health Science Reports
- Vol. 9 (3)
Aptamer‐Based Approaches for Influenza Virus Detection: A Systematic Review
Background and Aims: Influenza remains a globally prevalent respiratory infection that is challenging to diagnose accurately. This systematic review focuses on aptamer‐based tools for influenza virus detection, aiming to overcome the limitations of traditional diagnostic methods. Methods: Following PRISMA guidelines, we identified relevant studies from official databases (PubMed, Web of Science, Scopus, Embase, Google Scholar) and grey literature sources. The search strategy utilized keywords related to aptamers, systematic evolution of ligands by exponential enrichment (SELEX) techniques, and influenza. The qualitative synthesis included 22 articles out of 1432 studies. Results: Our analysis revealed diverse aptamer‐based techniques for influenza detection, including fluorescence resonance energy transfer (FRET)‐based aptasensors, electrochemical sensors, and surface‐enhanced raman scattering (SERS)‐based methods. SELEX was the predominant method for aptamer development, ensuring high specificity and adaptability to various influenza strains. Notably, FRET‐based methods demonstrated detection limits as low as 0.43 ng/mL, while electrochemical approaches exhibited high sensitivity with low detection limits in the picomolar range. The findings highlight the advantages of aptamers, including cost‐effectiveness, stability, and rapid synthesis, though challenges related to reproducibility and technological complexity remain. Conclusion: Aptamer‐based tools offer promising alternatives to traditional diagnostics, especially for rapid and field‐deployable influenza detection. Their adaptability and potential for multiplex detection underscore their role in advancing public health diagnostics. Further research should focus on optimizing sensitivity and simplifying technological requirements for broader clinical applications.
- 17 March 2026
- Published by Wiley in Health Science Reports
- Vol. 9 (3)
Open AccessAptamer‐Based Approaches for Influenza Virus Detection: A Systematic Review
Background and Aims: Influenza remains a globally prevalent respiratory infection that is challenging to diagnose accurately. This systematic review focuses on aptamer‐based tools for influenza virus detection, aiming to overcome the limitations of traditional diagnostic methods. Methods: Following PRISMA guidelines, we identified relevant studies from official databases (PubMed, Web of Science, Scopus, Embase, Google Scholar) and grey literature sources. The search strategy utilized keywords related to aptamers, systematic evolution of ligands by exponential enrichment (SELEX) techniques, and influenza. The qualitative synthesis included 22 articles out of 1432 studies. Results: Our analysis revealed diverse aptamer‐based techniques for influenza detection, including fluorescence resonance energy transfer (FRET)‐based aptasensors, electrochemical sensors, and surface‐enhanced raman scattering (SERS)‐based methods. SELEX was the predominant method for aptamer development, ensuring high specificity and adaptability to various influenza strains. Notably, FRET‐based methods demonstrated detection limits as low as 0.43 ng/mL, while electrochemical approaches exhibited high sensitivity with low detection limits in the picomolar range. The findings highlight the advantages of aptamers, including cost‐effectiveness, stability, and rapid synthesis, though challenges related to reproducibility and technological complexity remain. Conclusion: Aptamer‐based tools offer promising alternatives to traditional diagnostics, especially for rapid and field‐deployable influenza detection. Their adaptability and potential for multiplex detection underscore their role in advancing public health diagnostics. Further research should focus on optimizing sensitivity and simplifying technological requirements for broader clinical applications.
- 5 December 2025
- Published by Wiley in Reviews in Medical Virology
- Vol. 36 (1) , e70088
Dengue Fever: Viral, Environmental, and Human Factors Driving Expansion and Pandemic Risk
Dengue fever (DF), caused by the dengue virus (DENV), is the fastest‐spreading mosquito‐borne viral disease globally and presents significant public health challenges. This comprehensive review explores the multifaceted factors influencing DENV expansion and control. We examine viral factors, including serotypes, sub‐genotypes, genetic mutations, recombination, and immune evasion mechanisms, and their role in enhancing dengue's adaptability and virulence. The influence of environmental factors, such as climate change, global warming, and unplanned urbanization on mosquito vector distribution, and the impact of natural disasters and human conflicts on population dynamics and transmission risks are discussed. Human factors, including global travel, migration, inadequate public health infrastructure, and the role of herd immunity from previous infections and cyclical outbreaks, are critically assessed. Additionally, emerging challenges like co‐infections, drug resistance, and the potential for pandemic outbreaks are considered. By synthesizing current knowledge across these dimensions, this review provides insights into dengue transmission complexities and identifies key intervention areas, aiming to enhance strategies for prevention, control, and preparedness in the face of evolving global health threats.
- 5 December 2025
- Published by Wiley in Reviews in Medical Virology
- Vol. 36 (1) , e70088
Dengue Fever: Viral, Environmental, and Human Factors Driving Expansion and Pandemic Risk
Dengue fever (DF), caused by the dengue virus (DENV), is the fastest‐spreading mosquito‐borne viral disease globally and presents significant public health challenges. This comprehensive review explores the multifaceted factors influencing DENV expansion and control. We examine viral factors, including serotypes, sub‐genotypes, genetic mutations, recombination, and immune evasion mechanisms, and their role in enhancing dengue's adaptability and virulence. The influence of environmental factors, such as climate change, global warming, and unplanned urbanization on mosquito vector distribution, and the impact of natural disasters and human conflicts on population dynamics and transmission risks are discussed. Human factors, including global travel, migration, inadequate public health infrastructure, and the role of herd immunity from previous infections and cyclical outbreaks, are critically assessed. Additionally, emerging challenges like co‐infections, drug resistance, and the potential for pandemic outbreaks are considered. By synthesizing current knowledge across these dimensions, this review provides insights into dengue transmission complexities and identifies key intervention areas, aiming to enhance strategies for prevention, control, and preparedness in the face of evolving global health threats.
- Open Access
- 17 November 2025
- Published by Wiley in Health Science Reports
- Vol. 8 (11)
COVID‐19 Waves and Cardiac Health: An Investigative Analysis of Creatine Phosphokinase Levels and Troponin Status Using Machine Learning
Background: This study explores the correlation between creatine phosphokinase (CPK) levels and cardiac troponin status with eight waves of COVID‐19 and identifies the most significant biomarker for assessing disease severity. Methods: Participants were selected based on confirmed COVID‐19 diagnoses using RT‐PCR testing. Machine learning modeling with the PyCaret autoML library established a benchmark for classification models using variables such as age, gender, serum troponin, CPK, and COVID‐19 waves. Rigorous evaluation metrics were employed to assess model performance. Results: The analysis included 1975 COVID‐19 patients. Patient demographics showed a shift in age and gender distribution across different waves, with later waves characterized by younger patients and a greater proportion of females. Mortality rates varied, peaking at 34.5% in the third wave and dropping to 0% in the eighth wave. CPK levels differed significantly among waves, with the third wave having the highest levels and later waves showing the lowest levels. However, troponin positivity rates did not differ significantly among waves. An extra trees classifier model achieved an overall accuracy, micro‐average area under curve (AUC), sensitivity, and specificity of 0.79, 0.65, 0.79, and 0.89, respectively. CPK was identified as the most important predictor of patient outcome, followed by COVID‐19 wave, age, and gender, while troponin status had the least importance. Conclusion: These findings shed light on the potential relationship between CPK, troponin, and different waves of COVID‐19 and their impact on disease severity. This understanding could significantly contribute to future research and clinical practices, aiding in the management and mitigation of COVID‐19's cardiac implications.
- 17 November 2025
- Published by Wiley in Health Science Reports
- Vol. 8 (11)
Open AccessCOVID‐19 Waves and Cardiac Health: An Investigative Analysis of Creatine Phosphokinase Levels and Troponin Status Using Machine Learning
Background: This study explores the correlation between creatine phosphokinase (CPK) levels and cardiac troponin status with eight waves of COVID‐19 and identifies the most significant biomarker for assessing disease severity. Methods: Participants were selected based on confirmed COVID‐19 diagnoses using RT‐PCR testing. Machine learning modeling with the PyCaret autoML library established a benchmark for classification models using variables such as age, gender, serum troponin, CPK, and COVID‐19 waves. Rigorous evaluation metrics were employed to assess model performance. Results: The analysis included 1975 COVID‐19 patients. Patient demographics showed a shift in age and gender distribution across different waves, with later waves characterized by younger patients and a greater proportion of females. Mortality rates varied, peaking at 34.5% in the third wave and dropping to 0% in the eighth wave. CPK levels differed significantly among waves, with the third wave having the highest levels and later waves showing the lowest levels. However, troponin positivity rates did not differ significantly among waves. An extra trees classifier model achieved an overall accuracy, micro‐average area under curve (AUC), sensitivity, and specificity of 0.79, 0.65, 0.79, and 0.89, respectively. CPK was identified as the most important predictor of patient outcome, followed by COVID‐19 wave, age, and gender, while troponin status had the least importance. Conclusion: These findings shed light on the potential relationship between CPK, troponin, and different waves of COVID‐19 and their impact on disease severity. This understanding could significantly contribute to future research and clinical practices, aiding in the management and mitigation of COVID‐19's cardiac implications.
- Open Access
- 26 February 2025
- Published by Bentham Science Publishers Ltd. in The Open Dermatology Journal
- Vol. 19 (1)
Unraveling Dermatological Manifestations after COVID-19: Insights from Skin Pigmentation and Hair Loss Patterns
Introduction: In addition to respiratory symptoms, COVID-19 has been linked to many clinical manifestations, such as changes in skin pigmentation and hair loss. The objective of this research was to examine these manifestations. Methods: Cross-sectional research was performed at Afzalipour Hospital in Kerman, Iran, between June and August 2021. COVID-19-recovered patients were included in the study, and data were obtained via medical records, verbal interviews, and self-administered questionnaires. Statistical investigations evaluated the relationships between manifestations, demographic factors, and clinical indications. Results: Among the 190-study population, 76.3% encountered alopecia, while 15.3% indicated changes in skin pigmentation. The prevalence of hair loss was considerably higher among females (P=0.002). The hair loss patterns exhibited characteristics similar to telogen effluvium (TE), with a higher occurrence in the frontal region of the head. There was a relationship between hair loss and the level of arterial oxygen saturation. Conclusion: This research emphasizes a significant prevalence of alopecia after the recovery from COVID-19, especially among females. It is crucial to provide proactive care and support to people who have recovered from COVID-19, including customized therapies that specifically target post-COVID-19 problems.
- 26 February 2025
- Published by Bentham Science Publishers Ltd. in The Open Dermatology Journal
- Vol. 19 (1)
Open AccessUnraveling Dermatological Manifestations after COVID-19: Insights from Skin Pigmentation and Hair Loss Patterns
Introduction: In addition to respiratory symptoms, COVID-19 has been linked to many clinical manifestations, such as changes in skin pigmentation and hair loss. The objective of this research was to examine these manifestations. Methods: Cross-sectional research was performed at Afzalipour Hospital in Kerman, Iran, between June and August 2021. COVID-19-recovered patients were included in the study, and data were obtained via medical records, verbal interviews, and self-administered questionnaires. Statistical investigations evaluated the relationships between manifestations, demographic factors, and clinical indications. Results: Among the 190-study population, 76.3% encountered alopecia, while 15.3% indicated changes in skin pigmentation. The prevalence of hair loss was considerably higher among females (P=0.002). The hair loss patterns exhibited characteristics similar to telogen effluvium (TE), with a higher occurrence in the frontal region of the head. There was a relationship between hair loss and the level of arterial oxygen saturation. Conclusion: This research emphasizes a significant prevalence of alopecia after the recovery from COVID-19, especially among females. It is crucial to provide proactive care and support to people who have recovered from COVID-19, including customized therapies that specifically target post-COVID-19 problems.
- Open Access
- 25 February 2025
- Published by Wiley in Health Science Reports
- Vol. 8 (2) , e70464
Mpox and Viral Co‐Infections: A Narrative Review
Background and Aims: Monkeypox (Mpox), caused by the monkeypox virus (MPXV), has emerged as a significant global public health concern, particularly following a substantial multi‐country outbreak in mid‐2022. The World Health Organization (WHO) reported 109,699 laboratory‐confirmed Mpox cases and 236 fatalities worldwide from January 1, 2022, to September 30, 2024. This narrative review aims to evaluate the co‐infections of Mpox with various viral agents and assess their implications for public health.Methods: We conducted a comprehensive review of the literature regarding Mpox co‐infections with human immunodeficiency virus (HIV), severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), hepatitis viruses (hepatitis A virus (HAV), hepatitis B virus (HBV), and hepatitis C virus (HCV)), and herpesviruses (including herpes simplex virus (HSV)‐1, HSV‐2, varicella‐zoster virus (VZV), and cytomegalovirus (CMV)).Results: We analyzed epidemiological trends, clinical manifestations, preventive measures, treatment guidelines, and advanced diagnostic methodologies. The review highlights the intricate dynamics of Mpox co‐infections and underscores the necessity for comprehensive diagnostic approaches, including viral load assays, to evaluate active co‐infections, particularly for HIV and HBV.Conclusion: Understanding the interplay between MPXV and other viral pathogens is crucial for enhancing management strategies for co‐infections. By addressing these complexities, we aim to contribute valuable insights into the public health implications of Mpox co‐infections and improve response strategies.
- 25 February 2025
- Published by Wiley in Health Science Reports
- Vol. 8 (2) , e70464
Open AccessMpox and Viral Co‐Infections: A Narrative Review
Background and Aims: Monkeypox (Mpox), caused by the monkeypox virus (MPXV), has emerged as a significant global public health concern, particularly following a substantial multi‐country outbreak in mid‐2022. The World Health Organization (WHO) reported 109,699 laboratory‐confirmed Mpox cases and 236 fatalities worldwide from January 1, 2022, to September 30, 2024. This narrative review aims to evaluate the co‐infections of Mpox with various viral agents and assess their implications for public health.Methods: We conducted a comprehensive review of the literature regarding Mpox co‐infections with human immunodeficiency virus (HIV), severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), hepatitis viruses (hepatitis A virus (HAV), hepatitis B virus (HBV), and hepatitis C virus (HCV)), and herpesviruses (including herpes simplex virus (HSV)‐1, HSV‐2, varicella‐zoster virus (VZV), and cytomegalovirus (CMV)).Results: We analyzed epidemiological trends, clinical manifestations, preventive measures, treatment guidelines, and advanced diagnostic methodologies. The review highlights the intricate dynamics of Mpox co‐infections and underscores the necessity for comprehensive diagnostic approaches, including viral load assays, to evaluate active co‐infections, particularly for HIV and HBV.Conclusion: Understanding the interplay between MPXV and other viral pathogens is crucial for enhancing management strategies for co‐infections. By addressing these complexities, we aim to contribute valuable insights into the public health implications of Mpox co‐infections and improve response strategies.
- 8 November 2024
- Published by Taylor & Francis in Nanomedicine
- Vol. 19 (30) , 1-12
Exploring potential of graphene oxide as an alternative antiviral approach for influenza A H1N1
Aim: Graphene oxide (GO), known for its distinctive physicochemical properties, shows promise as a nanomaterial capable of combating infectious agents. This study investigates the efficacy of GO nanoparticles in restricting influenza A H1N1 replication in MDCK cells.Methods: GO nanoparticles were synthesized. After evaluating the toxicity of GO nanoparticles, the antiviral activity of the highest nontoxic concentration of GO against influenza A H1N1 in MDCK cells was studied.Results: GO treatments resulted in substantial decreases in virus titers, as shown via hemagglutination assay, TCID50 assay and real-time PCR analysis.Conclusion: This study emphasizes that GO nanoparticles have a high level of effectiveness against influenza A H1N1 viruses, making them an intriguing option for various antiviral uses.
- 8 November 2024
- Published by Taylor & Francis in Nanomedicine
- Vol. 19 (30) , 1-12
Exploring potential of graphene oxide as an alternative antiviral approach for influenza A H1N1
Aim: Graphene oxide (GO), known for its distinctive physicochemical properties, shows promise as a nanomaterial capable of combating infectious agents. This study investigates the efficacy of GO nanoparticles in restricting influenza A H1N1 replication in MDCK cells.Methods: GO nanoparticles were synthesized. After evaluating the toxicity of GO nanoparticles, the antiviral activity of the highest nontoxic concentration of GO against influenza A H1N1 in MDCK cells was studied.Results: GO treatments resulted in substantial decreases in virus titers, as shown via hemagglutination assay, TCID50 assay and real-time PCR analysis.Conclusion: This study emphasizes that GO nanoparticles have a high level of effectiveness against influenza A H1N1 viruses, making them an intriguing option for various antiviral uses.
- Open Access
- 29 October 2024
- Published by Springer Nature in BMC Cancer
- Vol. 24 (1) , 1-15
A narrative review: exploring viral-induced malignancies through the lens of dysregulated cellular metabolism and glucose transporters
In this narrative review, we unravel the complex interplay between oncogenic viruses, cellular metabolism, and glucose transporter (GLUT) dysregulation in viral-induced malignancies. By explaining the diverse mechanisms through which seven major oncoviruses manipulate metabolic pathways and GLUT expression, particularly GLUT1, we provide novel insights into the critical role of metabolic reprogramming in viral replication and oncogenesis. Our exploration of the molecular pathways targeted by viral oncoproteins reveals a similarity between the metabolic alterations induced by viral infections and those observed in neoplastic transformation. A key finding of our review is the overexpression of GLUTs, particularly GLUT1, as a hallmark of both viral infections and many cancers. By elucidating the complex interplay between viral oncoproteins, oncogene activation, tumor suppressor gene loss, and GLUT overexpression, we highlight the potential of GLUTs as novel targets for diagnosis, prognosis, and therapy of viral-induced malignancies.
- 29 October 2024
- Published by Springer Nature in BMC Cancer
- Vol. 24 (1) , 1-15
Open AccessA narrative review: exploring viral-induced malignancies through the lens of dysregulated cellular metabolism and glucose transporters
In this narrative review, we unravel the complex interplay between oncogenic viruses, cellular metabolism, and glucose transporter (GLUT) dysregulation in viral-induced malignancies. By explaining the diverse mechanisms through which seven major oncoviruses manipulate metabolic pathways and GLUT expression, particularly GLUT1, we provide novel insights into the critical role of metabolic reprogramming in viral replication and oncogenesis. Our exploration of the molecular pathways targeted by viral oncoproteins reveals a similarity between the metabolic alterations induced by viral infections and those observed in neoplastic transformation. A key finding of our review is the overexpression of GLUTs, particularly GLUT1, as a hallmark of both viral infections and many cancers. By elucidating the complex interplay between viral oncoproteins, oncogene activation, tumor suppressor gene loss, and GLUT overexpression, we highlight the potential of GLUTs as novel targets for diagnosis, prognosis, and therapy of viral-induced malignancies.